argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
870.00
-2.27 (-0.26%)
At close: Nov 11, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,303,490
Profits / Employee
$958,878
Market Cap
54.89B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
argenx SE News
- 2 days ago - ARGX: Morgan Stanley Raises Price Target to $1110, Maintains Overweight Rating | ARGX Stock News - GuruFocus
- 3 days ago - ARGX Quantitative Stock Analysis - Benjamin Graham - Nasdaq
- 7 days ago - If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today - Benzinga
- 8 days ago - Looking Into argenx SE's Recent Short Interest - Benzinga
- 10 days ago - argenx: Sights Set On $1,000 - Seeking Alpha
- 12 days ago - This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
- 12 days ago - ARGX Downgraded by Wolfe Research to 'Peer Perform' | ARGX Stock News - GuruFocus
- 15 days ago - Guru Fundamental Report for ARGX - Benjamin Graham - Nasdaq